Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Bristol-Myers Squibb and CytomX Therapeutics Extend Worldwide Collaboration to Discover Probody™ Therapeutics
Tuesday, March 21, 2017BristolMyers Squibb Company and CytomX Therapeutics Inc a biopharmaceutical company developing investigational Probody therapeutics for the treatment of cancer today announced an expansion of their strategic collaboration to discover novel therapies...
Array Biopharma provides NEMO update
Monday, March 20, 2017Array Biopharma provides NEMO update Array Biopharma Inc Has withdrawn from US FDA division of oncology products its new drug application NDA for binimetinib monotherapy Says ongoing clinical trials for binimetinib will continue Array Biophar...
J&J and Bayer's Xarel to cuts recurrence of dangerous blood clots in study
Monday, March 20, 2017Longerterm use of the oral blood thinner Xarelto significantly cut the risk of recurrence of potentially lifethreatening blood clots with no additional major bleeding compared with lowdose aspirin in patients at elevated risk according to data presen...
Threshold Pharmaceuticals and Molecular Templates Agree to Combine
Saturday, March 18, 2017Threshold Pharmaceuticals Inc a clinicalstage biopharmaceutical company developing novel therapies for cancer and Molecular Templates Inc a privately held biopharmaceutical company today jointly announced that they have entered into a definitive agre...
Acura Pharmaceuticals and MainPointe Pharmaceuticals Announce Deal for Nexafed® Products
Saturday, March 18, 2017Acura Pharmaceuticals Inc and MainPointe Pharmaceuticals LLC today announced that they have entered into a License Agreement the Agreement to have MainPointe exclusively market NEXAFED and NEXAFED Sinus in the US and Canada The pseudoephedrinecontain...
Alkermes Initiates Phase 3 Gastrointestinal Tolerability Study of ALKS 8700
Friday, March 17, 2017Alkermes plc announced the initiation of a new phase study of ALKS a novel oral monomethyl fumarate MMF prodrug candidate in development for the treatment of relapsing forms of multiple sclerosis MS ALKS is designed to rapidly and efficiently conv...
Kadimastem Granted a Patent in the US for Treatment of Neurodegenerative Diseases
Friday, March 17, 2017Israeli biotechnology company Kadimastem announced that it has been granted a patent from the United States Patent and Trademark Office for its technology in the field of cell based treatment for diseases of the nervous system The United States paten...
PTC Therapeutics Announces Agreement to Acquire Emflaza™ from Marathon Pharmaceuticals, LLC
Friday, March 17, 2017PTC Therapeutics Inc announced it has entered into an asset purchase agreement with Marathon Pharmaceuticals LLC to acquire all rights to Emflaza deflazacort Emflaza is the first treatment approved in the United States for all Duchenne muscular dystr...
Glycyx PharmaVentures and Valeant Pharmaceuticals Agree to Binding Terms of Licensing Agreement in the Field of Oncology
Thursday, March 16, 2017Glycyx PharmaVentures Ltd a biopharma investment and development company founded by Lorin K Johnson PhD has agreed to enter into an exclusive license agreement with Valeant Pharmaceuticals International Inc Valeant pursuant to which Valeant will gran...
Ferring Collaborates with ICF on Development of a Potential New Treatment for Anal Fissures
Thursday, March 16, 2017Ferring Pharmaceuticals and Brazilbased Instituto de Cincias Farmacuticas ICF today announced a research collaboration aimed at developing a mucoadhesive rectal delivery system to treat anal fissures and to improve quality of care for patients with i...
